LIke ThisLIke ThisLIke This

Todd  Golub, MD

Todd Golub, MD
Research Center:
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Medicine Research
Hematology/Oncology Research
Hospital Title:
Associate in Medicine
Academic Title:
Professor of Pediatrics, Harvard Medical School
Research Focus Area:
Cancer genetics

Research Overview

Todd Golub's laboratory focuses on the genetic basis of cancer, with particular emphasis on the utilization of new genomics and computer science approaches to cancer diagnosis and treatment planning. The laboratory has pioneered the use of DNA microarrays, or 'DNA chips,' for cancer diagnosis and is currently extending these techniques to gain insight into the molecular basis of human cancer. Part of this research effort involves the integration of computer science experts into the research group to extract clinically meaningful patterns from complex genetic information within tumors.

About Todd Golub

Todd Golub received his MD from the University of Chicago Pritzker School of Medicine. He competed an internship, residency, and fellowship at Children's Hospital Boston/Dana-Farber Cancer Institute. Todd is the recipient of multiple awards, including the 2009 AACR-Richard and Hinda Rosenthal Memorial Award, 2008 E. Mead Johnson Award from the Society for Pediatric Research, the 2007 Oski Prize of the American Society of Pediatric Hematology-Oncology, Discover Magazine’s Inventor of the Year (Health Category), the Daland Prize of the American Philosophical Society, the Outstanding Achievement Award from the American Association for Cancer Research, and the 2007 Paul Marks Prize for Cancer Research. Todd also serves on the Board of Scientific Advisors of the National Cancer Institute.

LIke ThisLIke ThisLIke This


Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top research centers in the world for pediatric cancers and blood diseases. It brings together laboratory scientists and clinical researchers from Dana-Farber Cancer Institute and Boston Children’s Hospital in a single program. We investigate pediatric cancers and non-malignant blood disorders from every angle—from examining cells under the microscope to tracking the effectiveness of current drug regimens using the most advanced molecular methods—so that we can create better treatments for children seen here and around the world.

Learn more